DK0628548T3 - 1,2,3,4-Tetraydro-acridinamin-derivater - Google Patents

1,2,3,4-Tetraydro-acridinamin-derivater

Info

Publication number
DK0628548T3
DK0628548T3 DK94112223T DK94112223T DK0628548T3 DK 0628548 T3 DK0628548 T3 DK 0628548T3 DK 94112223 T DK94112223 T DK 94112223T DK 94112223 T DK94112223 T DK 94112223T DK 0628548 T3 DK0628548 T3 DK 0628548T3
Authority
DK
Denmark
Prior art keywords
acridinamine
derivatives
tetraydro
agents
cerebral
Prior art date
Application number
DK94112223T
Other languages
English (en)
Inventor
Jeffrey Alan Kester
Colin Granger
Anthony Jerome Thomas
Walter Hamilton Moos
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of DK0628548T3 publication Critical patent/DK0628548T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08—Nitrogen atoms
    • C07D219/10—Nitrogen atoms attached in position 9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
DK94112223T 1989-07-31 1990-07-30 1,2,3,4-Tetraydro-acridinamin-derivater DK0628548T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/387,722 US4999430A (en) 1989-07-31 1989-07-31 Derivatives of 1,2,3,4-tetrahydro-9-acrisinamine

Publications (1)

Publication Number Publication Date
DK0628548T3 true DK0628548T3 (da) 2000-05-08

Family

ID=23531113

Family Applications (2)

Application Number Title Priority Date Filing Date
DK90114586.2T DK0411534T3 (da) 1989-07-31 1990-07-30 Derivater af 1,2,3,4-tetrahydro-9-acridinamin
DK94112223T DK0628548T3 (da) 1989-07-31 1990-07-30 1,2,3,4-Tetraydro-acridinamin-derivater

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK90114586.2T DK0411534T3 (da) 1989-07-31 1990-07-30 Derivater af 1,2,3,4-tetrahydro-9-acridinamin

Country Status (17)

Country Link
US (1) US4999430A (da)
EP (2) EP0411534B1 (da)
JP (1) JP2930245B2 (da)
KR (1) KR910002802A (da)
AT (2) ATE186908T1 (da)
AU (1) AU5994590A (da)
CA (1) CA2022297C (da)
DE (2) DE69033369T2 (da)
DK (2) DK0411534T3 (da)
ES (2) ES2068955T3 (da)
FI (1) FI903752A0 (da)
GR (1) GR3032539T3 (da)
IE (1) IE66823B1 (da)
NO (1) NO903359L (da)
NZ (1) NZ234672A (da)
PT (1) PT94849A (da)
ZA (1) ZA905978B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85741A (en) * 1987-03-17 1996-05-14 Hoechst Roussel Pharma Transformed Tetra-Hydroacridines Process for their preparation and pharmaceutical preparations containing A-amino-Tetra-Transformed Hydroacridines
FR2640508B1 (fr) * 1988-12-19 1994-07-01 Dietlin Francois Nouvelles compositions et nouveaux produits pharmaceutiques assurant la regeneration de leucocytes et leur emploi pour le traitement du syndrome immuno-deficitaire
JP2546919B2 (ja) * 1989-11-08 1996-10-23 三菱化学株式会社 ９ーアシルアミノテトラヒドロアクリジン誘導体
CA2029497C (en) * 1989-11-08 2002-06-04 Kunihiro Ninomiya (Deceased) 4-acylaminopyridine derivative
US5179100A (en) * 1992-03-09 1993-01-12 Hoechst-Roussel Pharmaceuticals Inc. 4,5-dihydropyrazolo[3,4-a]acridines
US5466696A (en) * 1992-09-10 1995-11-14 Warner Lambert Company Tacrine and cytochrome P450 oxidase inhibitors and methods of use
US5422350A (en) * 1992-09-10 1995-06-06 Warner-Lambert Company Nitrogen substituted acridine and cytochrome P450 inhibitors and methods of use
HU213107B (en) * 1994-02-23 1997-02-28 Egyt Gyogyszervegyeszeti Gyar Process for producing acetic acid derivatives and pharmaceutical compositions containing them
GB9716879D0 (en) * 1997-08-08 1997-10-15 Shire Int Licensing Bv Treatment of attention deficit disorders
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
ES2168926B1 (es) * 1999-12-14 2003-10-16 Prous Science S A Derivados de ciclopenta- ciclohexa- y ciclohepta (b)quinoleina, procedimiento para su fabricacion, utilizacion y composicion farmaceutica correspondiente.
WO2006004201A1 (ja) * 2004-07-01 2006-01-12 Eisai R & D Management Co., Ltd. 神経再生促進剤
CN1315810C (zh) * 2004-08-30 2007-05-16 北京理工大学 哌嗪桥联他克林双体衍生物及其合成方法
US20080188510A1 (en) * 2005-05-23 2008-08-07 Eisai R & D Management Co., Ltd. Novel methods using zonisamide
MX2012006580A (es) * 2009-12-11 2012-09-28 Genecode As Metodo para facilitar la sobrevivencia de celulas neurales usando mimeticos de ligandos (gfl) de la familia gdnf o activadores de la ruta de señalizacion de ret.
EA037187B1 (ru) 2010-02-09 2021-02-17 Дзе Джонс Хопкинс Юниверсити Способ и композиция для лечения когнитивного расстройства
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
US11160785B2 (en) 2013-03-15 2021-11-02 Agenebio Inc. Methods and compositions for improving cognitive function
EP2968237A4 (en) 2013-03-15 2016-08-31 Univ Johns Hopkins METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
AU2016268096B2 (en) 2015-05-22 2021-04-01 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4985430A (en) * 1987-12-03 1991-01-15 Mitsubishi Kasei Corporation 9-acylamino-tetrahydroacridine derivatives and memory enhancing agent containing said derivative as active ingredient

Also Published As

Publication number Publication date
FI903752A0 (fi) 1990-07-27
DE69017789D1 (de) 1995-04-20
ES2068955T3 (es) 1995-05-01
ATE119885T1 (de) 1995-04-15
ATE186908T1 (de) 1999-12-15
ES2141787T3 (es) 2000-04-01
IE66823B1 (en) 1996-02-07
CA2022297C (en) 2001-09-18
DK0411534T3 (da) 1995-07-24
EP0628548B1 (en) 1999-11-24
EP0411534A2 (en) 1991-02-06
US4999430A (en) 1991-03-12
CA2022297A1 (en) 1991-02-01
NZ234672A (en) 1991-11-26
DE69033369D1 (de) 1999-12-30
JPH0366670A (ja) 1991-03-22
KR910002802A (ko) 1991-02-26
AU5994590A (en) 1991-01-31
JP2930245B2 (ja) 1999-08-03
PT94849A (pt) 1991-04-18
NO903359D0 (no) 1990-07-30
EP0628548A1 (en) 1994-12-14
IE902751A1 (en) 1991-02-27
NO903359L (no) 1991-02-01
GR3032539T3 (en) 2000-05-31
EP0411534A3 (en) 1991-06-05
EP0411534B1 (en) 1995-03-15
DE69017789T2 (de) 1995-07-13
ZA905978B (en) 1992-04-29
DE69033369T2 (de) 2000-05-11

Similar Documents

Publication Publication Date Title
DE69033369D1 (de) 1,2,3,4-Tetrahydro-9-Akridinamine-Derivate
IT1229203B (it) Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
FI904204A0 (fi) Foerfarande foer framstaellning av cykliska aminosyraderivat och mellanprodukter.
ZA906057B (en) 4-(n-substituted amino)-2-butynyl-1-ureas and thioureas and derivatives thereof as centrally acting muscarinic agents
ES2009689A6 (es) Procedimiento para preparar derivados de 3-piperidina-carbaldehido-oxima.
NO177145C (no) Analogifremgangsmåte for fremstilling av 4,5,6,7-tetrahydroisotiazolo[4,5-cÅ-pyridinderivater og isomere
AU653802B2 (en) Condensed diazepinones
EP0276805A3 (en) Substituted 3-phenyl-7h-thiazoloû3,2-b¨û1,2,4¨triazin-7-ones, processes for their preparation, medicaments containing them and their use as well as some of the intermediates obtained during the preparation of said compounds
ES2008421A6 (es) Procedimiento para la obtencion de derivados de la pilocarpina.
DK0950053T3 (da) Hidtil ukendte benzoylalkyl.1,2,3,6-tetrahydropyridinderivater